MCS110 With BRAF/MEK Inhibition in Patients With Melanoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Melanoma
Related studies linked through entity extraction aliases.
Efficacy of Palbociclib in Advanced Acral Melanoma With Cell Cycle Gene Aberrations
- Status
- UNKNOWN
- Phase
- PHASE2
Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Status
- RECRUITING
- Phase
- N/A
Long Term Quality of Life in Melanoma Patients in Netherlands
- Status
- COMPLETED
- Phase
- N/A
Study of First-line Treatment Patterns and Clinical Outcomes in Patients With Advanced Melanoma in the United Kingdom
- Status
- COMPLETED
- Phase
- N/A
Survival Study for Participants Treated With Ipilimumab-Nivolumab Combination Therapy
- Status
- COMPLETED
- Phase
- N/A
REVEAL Study of NKTR-262 in Combination With NKTR-214 and Nivolumab in Patients With Locally Advanced / Metastatic Solid Tumor Malignancies
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
HDI Versus Chemotherapy as Systemic Adjuvant Therapy for Resected Mucosal Melanoma
- Status
- UNKNOWN
- Phase
- PHASE3
Preventing Lymphedema in Axillary Lymph Node Dissection
- Status
- TERMINATED
- Phase
- NA
Treating Patients With Melanoma and ALK Alterations With Ensartinib
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Identifying the Predictive Factors of Response to PD-1 or PD-L1 Antagonists
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
Generation of Cancer Antigen-Specific T-cells From Human Induced Pluripotent Stem Cells (iPSC) for Research and Potential FutureTherapy
- Status
- TERMINATED
- Phase
- N/A
A Study of BMS-986253 in Combination With Nivolumab or Nivolumab Plus Ipilimumab in Advanced Cancers
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
NY-ESO-1-redirected CRISPR (TCRendo and PD1) Edited T Cells (NYCE T Cells)
- Status
- TERMINATED
- Phase
- PHASE1
Safety of Intranodal ECI-006 in Melanoma Patients
- Status
- TERMINATED
- Phase
- PHASE1
A Study of APR-246 in Combination With Dabrafenib in Resistant Patients With BRAF V600 Mutant Melanoma
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
The Impact of Melanoma and Drug Treatment in the Real World
- Status
- COMPLETED
- Phase
- N/A
Combined Therapy of Nivolumab and Adoptive T Cell Therapy in Metastatic Melanoma Patients
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
How Microbes and Metabolism May Predict Skin Cancer Immunotherapy Outcomes
- Status
- TERMINATED
- Phase
- N/A